Evidence map›Paper›PMID 40392658›Full record

ArticleJACC. Case reports2025

Redo Transcatheter Aortic Valve Replacement for Migration of Myval Transcatheter Heart Valve in Pure Aortic Regurgitation.

Emmanuel Gall, Thomas Hovasse, Fabien Doguet, Pietro Laforgia, Annabelle Dinan, Julien Amour, Antoinette Neylon, Jérôme Garot, Philippe Garot, Mariama Akodad

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emmanuel GallInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France; Department of Cardiology, University Hospital of Lariboisiere, Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Cité, Paris, France; Inserm MASCOT - UMRS 942, University Hospital of Lariboisiere, Paris, France; MIRACL.ai Laboratory, Multimodality Imaging for Research and Artificial Intelligence Core Laboratory, University Hospital of Lariboisiere (AP-HP), Paris, France.
Thomas HovasseInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
Fabien DoguetInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
Pietro LaforgiaInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
Annabelle DinanInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
Julien AmourInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
Antoinette NeylonInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
Jérôme GarotInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
Philippe GarotInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France.
Mariama AkodadInstitut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Ramsay Santé, Massy, France. Electronic address: m.akodad@icps.com.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA 76-year-old patient with severe symptomatic aortic regurgitation, deemed inoperable, was referred for transcatheter aortic valve replacement. CASE SUMMARY: Preprocedural computed tomography revealed a large, noncalcified native aortic annulus (31.7 mm), making commercially available transcatheter heart valves (THVs) unsuitable. A 32-mm (+2 mL) Myval (Meril) THV was implanted with satisfactory immediate results. However, at day 7, delayed and asymptomatic migration into the left ventricular outflow tract with severe paravalvular leak occurred. Given surgical ineligibility, a 29-mm (+6 cc THV balloon overfilling) Sapien 3 (Edwards Lifesciences) THV was successfully deployed as a redo TAVR strategy, anchoring the migrated index THV. One-month follow-up showed excellent outcomes. DISCUSSION: Delayed THV migration in patients with native aortic regurgitation is a challenge. This case highlights redo TAVR as a viable rescue strategy, using multimodal imaging and precise procedural techniques. TAKE-HOME MESSAGE: Redo TAVR is a safe and effective approach to address late THV migration into the left ventricular outflow tract in selected patients.

Indexed as

aortic regurgitationMyval transcatheter heart valveredo TAVR

Identifiers

PMID40392658
PMCPMC12441535

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.